首页> 美国卫生研究院文献>Case Reports in Pediatrics >Neonatal Liver Failure and Congenital Cirrhosis due to Gestational Alloimmune Liver Disease: A Case Report and Literature Review
【2h】

Neonatal Liver Failure and Congenital Cirrhosis due to Gestational Alloimmune Liver Disease: A Case Report and Literature Review

机译:妊娠同种免疫性肝病引起的新生儿肝衰竭和先天性肝硬化:一例报道并文献复习

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Neonatal liver failure (NLF) is a major cause of neonatal morbidity and mortality, presenting as acute liver failure and/or congenital cirrhosis. Many affected patients show antenatal signs of fetal injury. There are several causes of NLF and early diagnosis is mandatory to elucidate the etiology and determine a specific treatment or the best management strategy. Gestational alloimmune liver disease associated with neonatal hemochromatosis (GALD-NH) is a rare but potentially treatable cause of NLF. It should be considered in any neonate with fetal signs of disease and postnatal signs of liver failure with no other identifiable causes. GALD-NH is often diagnosed late and patients are therefore referred late to specialized centers, delaying treatment. This case highlights the consequences of late diagnosis and treatment of GALD-NH and emphasizes the importance of a high grade of suspicion of this disease in order to refer the patient to a specialized center soon enough to perform the appropriate treatment.
机译:新生儿肝衰竭(NLF)是新生儿发病率和死亡率的主要原因,表现为急性肝衰竭和/或先天性肝硬化。许多受影响的患者表现出胎儿受伤的产前体征。 NLF的病因多种多样,必须尽早诊断以阐明病因并确定具体治疗方法或最佳治疗策略。与新生儿血色素沉着病(GALD-NH)相关的妊娠同种免疫肝病是一种罕见的但可治疗的NLF病因。在没有其他可确定原因的胎儿疾病征兆和肝衰竭产后征兆的新生儿中,应考虑使用该药物。 GALD-NH通常被诊断得较晚,因此将患者延迟到专科中心就诊,从而延误了治疗。该病例强调了GALD-NH的晚期诊断和治疗的后果,并强调了高度怀疑这种疾病的重要性,以便尽快将患者转诊至专业中心以进行适当的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号